FDA applicant
Trinity Biotech USA
FDA records 11 decisions for Trinity Biotech USA (Jamestown, NY) from 1999 to 2014: 11 510(k) clearances. Most are in product codes LSR (Reagent, Borrelia Serological Reagent) and MXJ (Enzyme Linked Immunosorbent Assay, Herpes…). Its devices cite 1 predicate, 0 of them its own earlier devices. 2 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Trinity Biotech USA’s devices, and how often a recall has named them.
FDA decisions per year
1in 2014
2026 so far, outlined.
Recalls per year
1in 2021
Class I Class II/III not classified
Planning a device like Trinity Biotech USA’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Trinity”
FDA records each applicant name separately; these may or may not be the same firm.